What is it?
any condition that damages the liver and affects its ability to function |
Progression: Healthy liver → Fatty Liver → Inflammation (hepatitis) → fibrosis of liver → cirrhosis liver (irreversible) |
AKA: Healthy liver → NAFLD → NASH → cirrhosis |
Causes
Hep A & C |
autoimmune disease |
liver cancer |
toxins (alcohol, smoking) |
metabolic conditions |
obesity |
DM |
hyperinsulinemia |
Biochem
Marker |
Expected in LD |
Explanation |
LFT (ALP, GGT & bilirubin) |
↑ |
Bile flow is blocked (biliary obstruction, intrahepatic extrahepatic). They can also rise with liver tumours or obesity |
AST & ALT |
↑ |
↑ ALT only = mild hepatic damage. ↑ ALT and AST = hepatic damage. Markers of recent (hours/days) liver injury (though AST can also rise with muscle damage. Damage to liver cells = release of AST and ALT (found in hepatocytes). |
CRP |
↑ |
Marker of inflammation |
Albumin & prealbumin |
↓ |
Indicate cirrhosis and end stage liver disease. Albumin is synthesised in the liver. Poor indicator of nutritional status in liver disease patients. Correlate with the progression and severity of LD. |
Vit A, D, E, K |
↓ |
Fat malabsorption (↓ bile) |
Zinc |
↓ |
Develops from low intake, poor absorption (↓ bile, ↓ albumin), and diuretic (treat ascites) loss; linked to taste changes, glucose issues, encephalopathy, poor healing, and weakened immunity. |
Thiamine |
↓ |
Stores & activates @ liver. ↓ hepatic reserves and alcohol intake preventing the conversion into its active form. |
B12 |
↓ (tissue), ↑ (serum) |
Reduced hepatic stores. Liver cells release stored B12 when damages. |
Folic Acid |
↓ |
Liver stores & metabolises folate into its active form. Reduced hepatic reserves |
Calcium |
↓ |
Vitamin D deficiencies |
Selenium |
↓ |
↓ absorption and intake |
|
|
Functions of the liver
P, CHO, F metabolism |
Drug metabolism |
Stores: fat sol-vits, zinc, iron, copper and magnesium |
Secretes bile – fat absorption |
Synthesis: albumin, prealbumin, retinol-binding protein & clotting factors |
Stores glycogen |
+ many more! |
Child Pugh Score
5-6 points |
Grade A = 85-100% survival rate. Well compensated. |
7-9 points |
Grade B = Significant functional compromise. 60-80% survival |
10-15 points |
Grade C = decompensated disease. 35-45% survival rate |
NIS
Liver stores glycogen = unable to regulate blood sugar. Needing small regular meals |
Maldigestion & malabsorption: reduced bile (fat malabsorption), pancreatic insufficiency |
Altered taste, nausea |
Portal hypertension: in advanced liver disease. Vessels in liver blocked (eg scaring) = Blood merges into portal vein in liver = ↑ pressure = backflow of blood |
|
Oesophageal varices - dilated Abnormal veins – may bleed = reduced oral intake, dysphagia, text-mod |
|
Ascites - Abdominal swelling caused by accumulation of fluid. Malnutrition ↑s risk. Can’t use a PEG. early satiety, fluid & NA restrictions |
|
Encephalopathy (HE)– alters brain function. Confusion, memory, shaky, trouble talk/walk. inability to self-feed, dysphagia, tiredness, malaise (general feeling unwell). Stage 0 (no abnormalities)-4 (coma) |
Jaundice: liver cirrhosis or liver cancer. Serum bilirubin >2.5-3 mg/dL. Loss of liver function to metabolise bilirubin (damaged hepatocytes) = bilirubin builds up |
Nut Reqs
USE DRY WEIGHT |
Compensated liver disease: 100-145kJ/kg/day (CQHHS) |
NASH, cirrhosis, transplantation, hepatic encephalopathy: 145 – 165 kJ/kg/day (CQHHS), ESPN = 30-35kcal/kg |
Protein: 1.2 -1.5 g/P/kg/d (CQHHS). 1.5 for cirrhosis |
Fat: Restrict if: signs of fat malabsorption. Don’t remove as it’s a source of fat-sol V & concentrated energy |
Na: 2g/day (CQHHS) |
Risk of deficiency (alcoholic liver disease): folate, Vit C, B group |
Prevent toxicity: Copper & magnesium |
Thiamine: 100mg OD-TDS |
Vitamin D: 400-800IU/day |
Vitamin K: 10mg every 4 weeks K: 10mg every 4 weeks |
Calcium: 1200-1500mg/day |
Zinc: multivitamin can be used |
|
|
Intervention
NAFLD: Weight loss – similar to T2DM – intensive lifestyle. |
↓ weight, lifestyle behaviours, euglycemia/normal lipids/normal BP = reduce portal hypertension |
CLD (NASH, Cirrhosis): HPHE. Malnutrition strategies. Maintain muscle mass. |
|
Screen malnutrition (RFH-NPT) and Sarcopenia (SARC-F) - Prevent sarcopenia, severe fatty liver, infections, LOS, mortality, HE |
|
Varices: softer foods without sharp edges to avoid bleeds |
|
Ascites – Na 60 mmol/day (ESPEN) |
|
EN (NGT) – intake is <70-80% of reqs (CQHHS) eg oesophageal varies. 1.5-2 kcal feed. |
|
PN – liver failure - 2-in-1 bag (no fat) |
|
Thiamine supplementation before PN to prevent Wernicke-Korsakoff syndrome |
|
Minimise fasting |
|
BCAA Supps (12-14g/day delivered in the evening before sleep) |
For alcoholic liver disease (not w/ cirrhosis): initial remove alcohol & treatment withdrawal S/S. Correct deficiencies. |
V&M affected by alcohol: ↓ folic acid, thiamine, B6, niacin, Vit K, Vit C, Vit D, Vit A, iron, K, Mg |
Refer |
EP. Speechie |
Consider |
DO THEY HAVE ASCITIES? Swallowing function, ability to self-feed, texture-mod, refeeding risk |
Strategies
Malnutrition strategies - ONS, EN/PN |
6-8 meals/day. Max. 6-7 hours without any intake (CQHHS) |
Monitoring
tolerance to feeds |
wt |
N/V/D |
nut deficiencies |
re-asses reqs |
restriction changes |
Example PESS
NAFLD: Excessive oral intake, Food and nutrition knowledge deficit |
NASH/Severe CLD: malnutrition, Inadequate protein-energy intake, Inadequate oral intake |
Guidelines & References
ESPEN guideline on clinical nutrition in liver disease (2019) |
ESPEN practical guideline: clinical nutrition in liver disease (2020) |
FEEDS Gastroenterology and liver disease |
Central Queensland Nutrition guidelines for liver disease management 2019 |
|